Clinical TrialsSearch results
Number of results: 419
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Recruiting
- Exploratory Trial with KOEDA01 in Patients with Acute Cholecystitis.
- Acute cholecystitis
- Okuzono Toru
- 2024-01-10
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Recruiting
- HLA tests in lung transplant
- advanced pulmonary disease
- Okada Yoshinori
- 2022-01-08
Recruiting
- The safety and efficacy of COVID-19 vaccines among lung transplant recipients
- lung transplant recipients
- Okada Yoshinori
- 2021-06-04
Other
- An exploratory clinical study on intermittent negative pressure chamber system in patients with critical limb ischemia
- Critical limb ischemia
- Ohura Norihiko
- 2022-01-05
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive advanced and/or metastatic colorectal cancer, evaluation of the safety and efficacy based on KRAS mutation status (T-CORE0801)
- 3rd line or later therapy for unresectable advanced and/or recurrent colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2009-01-31
Other
- Randomized pilot study comparing safety of irinotecan+S-1(IRIS)+bevacizumab and mFOLFIRI+bevacizumab for metastatic colorectal cancer (T-CORE0702)
- 1st line or 2nd line therapy for unresectable colorectal cancer
- NPO T-CORE (Tohoku Clinical Oncology Research and Education Society)
- 2007-07-22
Other
- Phase II study of irinotecan and tegafur gimeracil for NSCLC with EGFR mutation which resistant to EGFR-TKI
- Non-small-cell lung cancer
- North Japan Lung Cancer Study Group
- 2010-08-31